Evidence map›Paper›PMID 36466884›Full record

ArticleFrontiers in immunology2022

Case Report: Mutations in

Ying Pan, Hui Pan, Chunan Lian, Beiyan Wu, Jieying Lin, Guang Huang, Binglin Cui

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Identification of novelFrontiers in genetics · 2026
    Article
  3. Article
  4. Article
  5. Trends in the Epidemiology ofJournal of fungi (Basel, Switzerland) · 2023
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ying PanThe Department of Pediatrics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Hui PanThe Outpatient Department, Shantou Longhu People's Hospital, Shantou, Guangdong, China.
Chunan LianThe Department of Pediatrics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Beiyan WuThe Department of Pediatrics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Jieying LinThe Department of Pediatrics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Guang HuangThe Department of Pediatrics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Binglin CuiThe Department of Pediatrics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
First Affiliated Hospital of Shantou University Medical College · CNShantou University · CNYue Bei People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: As a form of severe combined immunodeficiency (SCID), Janus kinase 3 ( Case description: A 5-month-old Chinese girl presented with recurring fever and productive cough after BCG vaccination and ineffective antibiotic treatment. Chest CT demonstrated bilateral infiltrations, enlarged mediastinal and axillary lymph nodes, and hypoplasia of the thymus. Outcome: The patient died at 13 months of age due to severe infections and hepatic damage. Discussion: SCID should be recognized before inoculation of live-attenuated vaccines in children. Newborn screening for SCID is advocated. Further investigations are needed to better understand the pathogenicity of the variants and molecular mechanism of the JH7 domain of

Indexed as

Pneumonia, PneumocystisSevere Combined ImmunodeficiencyBCG VaccineFemaleHumansInfantJanus Kinase 3MutationVaccines, AttenuatedBCG VaccineJAK3 protein, humanJanus Kinase 3Vaccines, Attenuatedcase reportJAK3 deficiencyMycobacterium tuberculosisPneumocystis jiroveciisevere combined immunodeficiency

Identifiers

PMID36466884
PMCPMC9712176
OpenAlexW4309609827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.